Influenza vaccine efficacy in patients aged 60–75 years in the 2016/2017 season

Journal Title: Family Medicine & Primary Care Review - Year 2018, Vol 20, Issue 3

Abstract

Background. From among the available and scientifically verified methods, vaccination every flu season is one of the most effective methods that aim at preventing flu, post-influenza complications and deaths. Its efficacy in preventing hospitalisation in patients over 65 years of age is 50–60%, and in preventing death from influenza and its complications, even up to 80%. Objectives. The aim of the study was the assessment of influenza vaccine efficacy in patients aged 60–75 years in the 2016/2017 season. Material and methods. The study included 96 patients aged 60–75 years. BMI, as well as the initial level of haemagglutinin H1, H3, HB antibodies, were determined for all patients. All subjects were vaccinated with trivalent seasonal vaccine (Vaxigrip). In the period of 4–5 weeks after vaccination, the level of haemagglutinin H1, H3, HB antibodies was measured again in all patients. Results. GMTs for all anti-haemagglutinins before and after vaccination differ significantly (p < 0.00001). The protection rate is higher after the vaccination than before for all anti-haemagglutinins, and these differences are statistically significant (p < 0.00001). In respect of each anti-haemagglutinin, the protection rate significantly exceeds the 60% threshold. The study showed proper immunogenicity of the influenza vaccine in the group of elderly people. Conclusions. The influenza vaccination induces a proper immune response in patients aged 60–75, and therefore, it should be recommended in such patients as a form of effective protection against influenza and its complications

Authors and Affiliations

Agata Sławin, Lidia Brydak, Zbigniew Doniec, Agnieszka Mastalerz-Migas

Keywords

Related Articles

The Internet as a source of health-related information among Internet users in the Lodz region, Poland

Background. The Internet is a widely used medium and a popular source of health-related information for patients. Currently, 59% of European Union citizens use it for such purpose. Due to the disputable quality of medica...

Evaluation of the occurrence of anxiety in pregnant women with regard to environmental conditions

Background. A mother’s health, her family relations and social-economic conditions are factors which determine the course of pregnancy, childbirth and puerperal period. Objectives. The main aim of the study was analysis...

Wykorzystanie karty FINDRISC jako narzędzia oceny ryzyka rozwoju cukrzycy w populacji pacjentów z nadciśnieniem tętniczym w wieku podeszłym

Wstęp. Populacja pacjentów z nadciśnieniem tętniczym (NT ) jest grupą szczególnie narażoną na wystąpienie zgonu z przyczyn sercowo-naczyniowych. NT występuje u blisko 30% dorosłej populacji i odsetek ten wzrasta z wiekie...

Jakość życia kobiet w okresie menopauzy

Wstęp. Jakość życia oznacza stopień satysfakcji z życia i poziom samorealizacji, na który wpływ ma funkcjonowanie człowieka w wymiarze fizycznym, psychicznym i społecznym. Cel pracy. Ocena jakości życia kobiet w okresie...

Przyczyny hospitalizacji w oddziale pediatrii ogólnej w wybranym szpitalu dziecięcym w latach 2006–2010

Wstęp. Problemy zdrowotne będące przyczyną hospitalizacji to głównie choroby wieku dziecięcego, które ze względu na przebieg lub towarzyszące powikłania wymagają leczenia szpitalnego. Cel pracy. Analiza problemów zdrowo...

Download PDF file
  • EP ID EP488669
  • DOI -
  • Views 50
  • Downloads 0

How To Cite

Agata Sławin, Lidia Brydak, Zbigniew Doniec, Agnieszka Mastalerz-Migas (2018). Influenza vaccine efficacy in patients aged 60–75 years in the 2016/2017 season. Family Medicine & Primary Care Review, 20(3), 263-266. https://europub.co.uk/articles/-A-488669